By reviewing the data and tweets, can we predict if the closing price of $mrk will go upwards or downwards at 2020-04-24? Please indicate either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2020-04-09,-1.6,1.0,-2.8,1.1,1.1,-3.2,-6.0,-9.2,-9.8,-8.9,-8.1
2020-04-13,1.6,2.4,-0.9,-2.4,-2.4,0.2,-2.6,-6.2,-7.4,-6.7,-5.7
2020-04-14,-0.6,0.4,-2.5,2.9,2.9,-2.0,-4.6,-7.5,-9.2,-9.1,-8.2
2020-04-15,-1.0,1.1,-1.8,-0.9,-0.9,-0.2,-3.1,-5.6,-7.9,-8.1,-7.2
2020-04-16,-0.4,0.4,-0.9,1.1,1.1,-1.0,-3.1,-5.4,-8.2,-8.9,-8.1
2020-04-17,0.6,0.8,-1.2,0.6,0.6,-1.3,-2.8,-5.1,-8.0,-9.0,-8.5
2020-04-20,-0.3,1.2,-2.8,-0.4,-0.4,-0.2,-1.6,-3.8,-6.9,-8.3,-8.0
2020-04-21,3.9,4.8,-0.4,-5.5,-5.5,4.4,3.9,1.9,-0.7,-2.5,-2.7
2020-04-22,-1.0,0.8,-1.4,1.8,1.8,2.1,2.2,0.3,-1.8,-4.0,-4.4
2020-04-23,-0.9,1.2,-0.9,1.1,1.1,0.4,1.0,-0.2,-2.1,-4.6,-5.4

2020-04-10: debt listing and trading are open.   $acb $apha $cron $trtc $cann $gwph $mcig $mjna $ammj $grnh $cara $cana $tsla $codi $cvsi $digp  $mdcl $mntr $mjne $mydx $nmus $ntrr $nhle $ndev $oxis $prre $rmhb $
2020-04-15: $mrk merck announced the us launch of its herceptin biosimilar, ontruzant, at a wac representing a 15% discount to current prices. $rhhbyontruzant is the 5th biosimilar of herceptin to launch in the u
2020-04-17: $aytu accuracy =98.0% and 94.1% for igg and igmAT_USER  AT_USER  AT_USERAT_USER AT_USER AT_USER AT_USERAT_USER AT_USER AT_USERAT_USER AT_USER$gild $mrk $mrna $ibio$ibio $decn $gild $ino $gsk $sny $jnj
2020-04-18: 6 of 10 $mcd $mmm $mrk |northwest biotherapeutics will announce glioblastoma phase 3 top line data by end of june or early july 2020, which will include idh mutation status and strengthened mgmt statu
2020-04-22: AT_USER i’d  buy stocks and definitely dinner! ?? $mrkyle815 
2020-04-23: $a $mrk - fda oks agilent companion test to merck's keytruda 
Answer:
Rise